Hormone optimization pairs powerfully with GLP-1 therapy for more complete metabolic results
GLP-1 Management for PCOS At PCOS Sisters, we provide GLP-1 treatment designed specifically for women with PCOS
Across STEP 1 and 3 trials involving non-diabetic participants, semaglutide 2.4 mg exhibited average placebo-adjusted weight reductions of 12.4% and 10.3%, respectively, by week 68
These medications and weight loss regimes, whether a keto diet, carnivore diet, etc., have to be a lifestyle change
Retatrutide Regulatory Status As of June 2026, retatrutide is not approved by the FDA, the EMA, or any other regulatory agency
Significant fluctuations in blood sugar levels can damage blood vessels in the retina if not well-controlled, potentially leading to serious vision problems and even blindness if left untreated